Clarity on which technology and regulatory projects will deliver the vision for the future.
Conduct more detailed design and engineering to show value of NIIMBL projects.
Detailed business case for integrated continuous bioprocessing (ICB) with capital cost estimates.
Line of sight from corporate manufacturing goals to NIIMBL projects.
Erickson, J., Presenter, Factory of the Future ICB Conference, ECI Integrated Continuous Manufacturing, Leesburg, VA, October 23, 2024
Erickson, J., Szuszkiewicz, R., Presenters, Bioprocess International West, Bioprocessing Facility Conceptual Design and Economics, San Diego, CA, March 13, 2024
Erickson, J., Workshop Chair, Factory of the Future and Enabling Technologies Workshop, NIIMBL National Meeting, Washington, DC, June 25, 2024
Szuszkiewicz, R., Presenter, NIIMBL Next Generation Manufacturing Facility, NIIMBL National Meeting, Washington, D.C., June 25, 2025.
Login to the NIIMBL member portal to access additional project information, including presentations, progress updates, reports, and more.
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

NIIMBL
Amgen Inc.
AstraZeneca
Bristol-Myers Squibb
CSL Behring, LLC
Cytiva
EMD Millipore Corporation
Eli Lilly and Company
Genentech, Inc.
GlaxoSmithKline, LLC
IPS-Integrated Project Services, LLC
Janssen Research & Development, LLC
Merck Sharp & Dohme LLC
Pfizer, Inc.
Sanofi
Sartorius Stedim
Takeda Pharmaceuticals